In our study, BCL-xL was overexpressed in SCL-1 cells compared to normal (healthy) cells, which is in line with data of patients with cutaneous squamous cell carcinoma (cSCC) having elevated BCL-xL levels as well (Vasiljević et al. 2009). The gene discussed is BCL2L1; the disease is cutaneous squamous cell carcinoma.